Price $26.50 |
Market Cap
184.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
9.2
|
P/B
2.47
|
P/S
2.25
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
12.6
|
Op. Cash Flow
15.7K
|
FCF
2.0
|
|
Op. Margin
23.40%
|
Net Margin
24.80%
|
ROE
31.00%
|
ROI
32.80%
|
|
ROA
21.40%
|
EPS Growth
32.10%
|
Current Ratio
2.2
|
Debt/Equity
4.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Encision Inc (ECIA) | $0.47 | - | - | 4.4M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.41 | - | - | 68M | Strong Buy |
| NovaBay Pharmaceuticals, Inc. (NBY) | $4.55 | - | - | 61.2M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.31 | - | - | 3.9M | Strong Buy |
| CV Sciences Inc (CVSI) | $0.24 | - | - | 22.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
